Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

[Effect of bufalin combined gefitinib on lung cancer H1975 cells and its mechanisms research].

Kang XH, Gong YB, Wang LF, Wang ZQ, Deng HB, Zhao XZ, Wu J, Xu ZY.

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2013 Aug;33(8):1081-5. Chinese.

PMID:
24325059
2.

[Bufalin reverses hepatocyte growth factor-induced resistance to afatinib in H1975 lung cancer cells].

Kang X, Lu P, Cui Y, Wang Y, Zhang Q, Gong Y, Xu Z.

Zhonghua Zhong Liu Za Zhi. 2015 Jul;37(7):490-6. Chinese.

PMID:
26463323
3.

Blocking the PI3K/AKT and MEK/ERK signaling pathways can overcome gefitinib-resistance in non-small cell lung cancer cell lines.

Li H, Schmid-Bindert G, Wang D, Zhao Y, Yang X, Su B, Zhou C.

Adv Med Sci. 2011;56(2):275-84. doi: 10.2478/v10039-011-0043-x.

PMID:
22037177
4.

[Tumor microenvironment elicits primary resistance to afatinib through HGF secretion].

Kang XH, Wang LF, Cao F, Fan FT, Xu ZY.

Zhonghua Zhong Liu Za Zhi. 2013 Oct;35(10):732-6. Chinese.

PMID:
24378092
5.

Effects of PI3K inhibitor NVP-BKM120 on acquired resistance to gefitinib of human lung adenocarcinoma H1975 cells.

Liang YC, Wu HG, Xue HJ, Liu Q, Shi LL, Liu T, Wu G.

J Huazhong Univ Sci Technolog Med Sci. 2013 Dec;33(6):845-51. doi: 10.1007/s11596-013-1209-5. Epub 2013 Dec 13.

PMID:
24337846
6.

Marsdenia tenacissima extract restored gefitinib sensitivity in resistant non-small cell lung cancer cells.

Han SY, Zhao MB, Zhuang GB, Li PP.

Lung Cancer. 2012 Jan;75(1):30-7. doi: 10.1016/j.lungcan.2011.06.001. Epub 2011 Jul 16.

PMID:
21757251
7.

Combined gefitinib and pemetrexed overcome the acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.

Wu M, Yuan Y, Pan YY, Zhang Y.

Mol Med Rep. 2014 Aug;10(2):931-8. doi: 10.3892/mmr.2014.2243. Epub 2014 May 16.

PMID:
24840891
8.

Bufalin inhibits gefitinib resistant NCI-H460 human lung cancer cell migration and invasion in vitro.

Huang AC, Yang MD, Hsiao YT, Lin TS, Ma YS, Peng SF, Hsia TC, Cheng YD, Kuo CL, Chung JG.

J Ethnopharmacol. 2016 Dec 24;194:1043-1050. doi: 10.1016/j.jep.2016.11.004. Epub 2016 Nov 7.

PMID:
27833027
9.

Antitumor activity of selective MEK1/2 inhibitor AZD6244 in combination with PI3K/mTOR inhibitor BEZ235 in gefitinib-resistant NSCLC xenograft models.

Qu Y, Wu X, Yin Y, Yang Y, Ma D, Li H.

J Exp Clin Cancer Res. 2014 Jun 17;33:52. doi: 10.1186/1756-9966-33-52.

10.

Combined treatment with Epimedium koreanum Nakai extract and gefitinib overcomes drug resistance caused by T790M mutation in non-small cell lung cancer cells.

Song J, Zhong R, Huang H, Zhang Z, Ding D, Yan H, Sun E, Jia X.

Nutr Cancer. 2014;66(4):682-9. doi: 10.1080/01635581.2014.895392. Epub 2014 Apr 16.

PMID:
24738693
11.

Bufalin induces lung cancer cell apoptosis via the inhibition of PI3K/Akt pathway.

Zhu Z, Sun H, Ma G, Wang Z, Li E, Liu Y, Liu Y.

Int J Mol Sci. 2012;13(2):2025-35. doi: 10.3390/ijms13022025. Epub 2012 Feb 14.

12.

The reverse effect of X-ray irradiation on acquired gefitinib resistance in non-small cell lung cancer cell line NCI-H1975 in vitro.

Wang J, Wei H, Zhao B, Li M, Lv W, Lv L, Song B, Lv S.

J Mol Histol. 2014 Dec;45(6):641-52. doi: 10.1007/s10735-014-9583-2. Epub 2014 Jul 10.

PMID:
25008024
13.

Knockdown of the Bcl-2 gene increases sensitivity to EGFR tyrosine kinase inhibitors in the H1975 lung cancer cell line harboring T790M mutation.

Zou M, Xia S, Zhuang L, Han N, Chu Q, Chao T, Peng P, Chen Y, Gui Q, Yu S.

Int J Oncol. 2013 Jun;42(6):2094-102. doi: 10.3892/ijo.2013.1895. Epub 2013 Apr 12.

PMID:
23588221
14.

The synergistic effect of EGFR tyrosine kinase inhibitor gefitinib in combination with aromatase inhibitor anastrozole in non-small cell lung cancer cell lines.

Shen L, Li Z, Shen S, Niu X, Yu Y, Li Z, Liao M, Chen Z, Lu S.

Lung Cancer. 2012 Dec;78(3):193-200. doi: 10.1016/j.lungcan.2012.08.012. Epub 2012 Sep 15.

PMID:
22985911
15.

[Sequence-dependent effect of docetaxel with gefitinib on the proliferation and signal protein expression of human lung adenocarcinoma cell SPC-A1].

Zhang W, Zhang W, Wang L, Zheng J, Xiao F.

Zhongguo Fei Ai Za Zhi. 2011 May;14(5):385-90. doi: 10.3779/j.issn.1009-3419.2011.05.01. Chinese.

16.

Combination of SF1126 and gefitinib induces apoptosis of triple-negative breast cancer cells through the PI3K/AKT-mTOR pathway.

Deng M, Wang J, Chen Y, Zhang L, Liu D.

Anticancer Drugs. 2015 Apr;26(4):422-7. doi: 10.1097/CAD.0000000000000202.

PMID:
25588160
17.

Curcumin induces EGFR degradation in lung adenocarcinoma and modulates p38 activation in intestine: the versatile adjuvant for gefitinib therapy.

Lee JY, Lee YM, Chang GC, Yu SL, Hsieh WY, Chen JJ, Chen HW, Yang PC.

PLoS One. 2011;6(8):e23756. doi: 10.1371/journal.pone.0023756. Epub 2011 Aug 17.

18.

Everolimus synergizes with gefitinib in non-small-cell lung cancer cell lines resistant to epidermal growth factor receptor tyrosine kinase inhibitors.

Dong S, Zhang XC, Cheng H, Zhu JQ, Chen ZH, Zhang YF, Xie Z, Wu YL.

Cancer Chemother Pharmacol. 2012 Nov;70(5):707-16. doi: 10.1007/s00280-012-1946-3. Epub 2012 Sep 2.

PMID:
22941374
19.

Melatonin sensitizes H1975 non-small-cell lung cancer cells harboring a T790M-targeted epidermal growth factor receptor mutation to the tyrosine kinase inhibitor gefitinib.

Yun M, Kim EO, Lee D, Kim JH, Kim J, Lee H, Lee J, Kim SH.

Cell Physiol Biochem. 2014;34(3):865-72. doi: 10.1159/000366305. Epub 2014 Aug 21.

20.

Degradation of Mcl-1 through GSK-3β Activation Regulates Apoptosis Induced by Bufalin in Non-Small Cell Lung Cancer H1975 Cells.

Kang XH, Zhang JH, Zhang QQ, Cui YH, Wang Y, Kou WZ, Miao ZH, Lu P, Wang LF, Xu ZY, Cao F.

Cell Physiol Biochem. 2017;41(5):2067-2076. doi: 10.1159/000475438. Epub 2017 Apr 14.

Supplemental Content

Support Center